Skip to main content

Table 2 Prevalence of comorbidities in South Australian population and association with 1-year all-cause mortality

From: Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians

Comorbidity

n (%)

Aboriginal aHR (95% CI)a

weight

n (%)

non-Aboriginal aHR (95% CI) a

weight

Alcohol abuse

77 (9.9)

1.73 (1.25–2.39)

2

13 (1.7)

1.07 (0.44–2.64)

1

AMI

32 (4.1)

1.24 (0.75–2.04)

1

8 (1.0)

0.68 (0.21–2.18)

0

Angina

38 (4.9)

1.21 (0.78–1.89)

1

13 (1.7)

2.48 (1.06–5.82)

2

Anxiety and behavioural disorders

14 (1.8)

1.08 (0.44–2.66)

1

8 (1.0)

1.46 (0.35–6.01)

1

Blood loss anaemia

11 (1.4)

1.42 (0.52–3.88)

1

**

**

**

Bowel disease

18 (2.3)

1.10 (0.54–2.25)

1

5 (0.6)

11.17 (3.73–33.5)

11

Cardiac arrhythmias

30 (3.9)

0.80 (0.46–1.41)

0

22 (2.8)

0.99 (0.46–2.14)

0

CHF

36 (4.6)

1.48 (0.96–2.28)

1

14 (1.8)

2.09 (1.00–4.37)

2

Chronic viral hepatitis

18 (2.3)

0.97 (0.45–2.10)

0

**

**

**

Coagulopathy

18 (2.3)

1.06 (0.46–2.41)

1

9 (1.2)

1.36 (0.42–4.49)

1

COPD

83 (10.7)

1.13 (0.81–1.59)

1

34 (4.4)

1.64 (0.92–2.90)

2

CVD

26 (3.4)

1.33 (0.74–2.40)

1

15 (1.9)

2.12 (1.07–4.13)

2

Deficiency anaemia

22 (2.8)

1.07 (0.56–2.01)

1

14 (1.8)

0.81 (0.29–2.27)

0

Dementia

6 (0.8)

0.67 (0.16–2.72)

0

**

**

**

Depression

20 (2.6)

1.00 (0.49–2.04)

1

9 (1.2)

1.14 (0.28–4.64)

1

Diabetes complicated

58 (7.5)

1.13 (0.76–1.68)

1

6 (0.8)

1.27 (0.17–9.31)

1

Diabetes without complications

84 (10.8)

1.01 (0.72–1.42)

1

21 (2.7)

2.67 (1.39–5.13)

3

Drug abuse

29 (3.7)

0.97 (0.54–1.75)

0

6 (0.8)

2.34 (0.73–7.52)

2

Epilepsy

13 (1.7)

1.26 (0.55–2.88)

1

6 (0.8)

4.11 (1.27–13.3)

4

Eye problems

16 (2.1)

1.50 (0.83–2.70)

1

**

**

**

Fluid and electrolyte disorders

18 (2.3)

1.43 (0.75–2.71)

1

9 (1.2)

3.22 (1.40–7.38)

3

Hypertension uncomplicated

105 (13.5)

1.01 (0.74–1.38)

1

55 (7.1)

1.07 (0.63–1.80)

1

Hypothyroidism

12 (1.5)

1.77 (0.78–4.04)

2

**

**

**

Intestinal disorders

14 (1.8)

0.86 (0.35–2.12)

0

15 (1.9)

0.58 (0.18–1.85)

0

Joint and spinal disorders

5 (0.6)

2.62 (0.64–10.8)

3

**

**

**

Metabolic disorders

48 (6.2)

1.31 (0.88–1.95)

1

13 (1.7)

0.87 (0.32–2.36)

0

Mild liver disease

24 (3.1)

2.00 (1.17–3.40)

2

**

**

**

Moderate/Severe liver disease

**

**

**

6 (0.8)

3.23 (1.29–8.05)

3

Obesity

17 (2.2)

0.61 (0.22–1.64)

0

**

**

**

Osteoporosis

6 (0.8)

0.82 (0.26–2.59)

0

**

**

**

Other cardiac conditions

58 (7.5)

1.34 (0.92–1.95)

1

14 (1.8)

2.97 (1.35–6.56)

3

Other neurological disorders

11 (1.4)

0.90 (0.28–2.85)

0

**

**

**

Pancreatitis

6 (0.8)

0.80 (0.20–3.23)

0

**

**

**

Paralysis

13 (1.7)

1.89 (0.83–4.30)

2

9 (1.2)

2.31 (1.06–5.02)

2

Peptic ulcer

18 (2.3)

0.95 (0.46–1.94)

0

15 (1.9)

1.25 (0.51–3.09)

1

Psychoses

23 (3)

1.43 (0.75–2.72)

1

8 (1.0)

1.10 (0.27–4.46)

1

Pulmonary circulation disorders

7 (0.9)

0.79 (0.29–2.20)

0

**

**

**

PVD

6 (0.8)

0.23 (0.03–1.67)

0

6 (0.8)

1.23 (0.30–5.02)

1

Renal disease

34 (4.4)

2.37 (1.55–3.62)

2

5 (0.6)

8.56 (2.53–28.9)

9

Rheumatoid disease

7 (0.9)

1.77 (0.65–4.84)

2

6 (0.8)

1.77 (0.65–4.84)

2

Sleep disorders

5 (0.6)

1.91 (0.60–6.08)

2

**

**

**

Urinary tract disorders

7 (0.9)

2.19 (0.87–5.52)

2

**

**

**

Valvular diseases

13 (1.7)

1.48 (0.65–3.39)

1

6 (0.8)

1.46 (0.20–10.7)

1

Weight loss

17 (2.2)

2.97 (1.71–5.16)

3

7 (0.9)

1.21 (0.30–4.94)

1

  1. Abbreviations: AMI acute myocardial infarction, COPD chronic obstructive pulmonary diseases, CVD cerebrovascular disease, CHF congestive heart failure
  2. aadjusted for age, sex, stage, primary site
  3. **excluded from the model, prevalence = < 0.5%